355 related articles for article (PubMed ID: 2827424)
21. Establishment and characterization of a fibrous histiocytoma cell line (NMSG 10) derived from a malignant fibrous histiocytoma.
Yokota T; Ishizaki R; Ohishi H; Ohami H
Pathol Res Pract; 1995 Dec; 191(12):1231-8. PubMed ID: 8927571
[TBL] [Abstract][Full Text] [Related]
22. Characterization of two cell lines, derived from two malignant fibrous histiocytomas.
Roholl PJ; Kleyne J; Van Blokland M; Spies PL; Rutgers DH; Albus-Lutter CE; Van Unnik JA
J Pathol; 1986 Oct; 150(2):103-12. PubMed ID: 3025391
[TBL] [Abstract][Full Text] [Related]
23. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
[TBL] [Abstract][Full Text] [Related]
24. Fibrous histiocytoma: benign and malignant variants.
Barsoum MS; Eissa SS; Mansour MA
Ann R Coll Surg Engl; 1979 Mar; 61(2):149-51. PubMed ID: 219749
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.
Kideryová L; Lacina L; Dvoránková B; Stork J; Cada Z; Szabo P; André S; Kaltner H; Gabius HJ; Smetana K
J Dermatol Sci; 2009 Jul; 55(1):18-26. PubMed ID: 19414239
[TBL] [Abstract][Full Text] [Related]
26. Oral fibrous histiocytoma and its angiomatoid variant.
Rullo R; Ferraraccio F; Serpico R; Addabbo F; Mazzarella N; Festa VM
J Craniomaxillofac Surg; 2012 Jul; 40(5):435-8. PubMed ID: 21875810
[TBL] [Abstract][Full Text] [Related]
27. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of fibronectin in soft tissue tumours using the immunoperoxidase technique.
Du Boulay CE
Diagn Histopathol; 1982; 5(4):283-9. PubMed ID: 6188591
[TBL] [Abstract][Full Text] [Related]
29. New entities in cutaneous soft tissue tumours.
Calonje E; Fletcher CD
Pathologica; 1993; 85(1095):1-15. PubMed ID: 8390634
[TBL] [Abstract][Full Text] [Related]
30. [Histogenesis of malignant fibrous histiocytoma and giant-cell tumor of bone].
Petrovichev NN; Chobonian NS; Annamukhamed AA; Khodzhamuratov DKh
Arkh Patol; 1985; 47(7):11-6. PubMed ID: 2996470
[TBL] [Abstract][Full Text] [Related]
31. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
Oshiro Y; Fukuda T; Tsuneyoshi M
Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
[TBL] [Abstract][Full Text] [Related]
32. [The proteolytic pretreatment of formalin-fixed tissue in immunohistochemical diagnosis].
Bahn H
Acta Histochem Suppl; 1988; 35():151-8. PubMed ID: 2458612
[TBL] [Abstract][Full Text] [Related]
33. [Malignant fibrous histiocytoma. Prognostic value of the histological findings].
Donhuijsen K; Kroll M; Krause U
Dtsch Med Wochenschr; 1986 Jan; 111(2):46-51. PubMed ID: 3000721
[TBL] [Abstract][Full Text] [Related]
34. [Malignant fibrous histiocytomas].
Kallweit C; Pfeiff B; Pullmann H
Z Hautkr; 1986 Sep; 61(18):1299-302, 1307-8. PubMed ID: 3022494
[TBL] [Abstract][Full Text] [Related]
35. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
Moosavi C; Jha P; Fanburg-Smith JC
Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
[TBL] [Abstract][Full Text] [Related]
36. Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study.
Thoolen RJ; Vos JH; van der Linde-Sipman JS; de Weger RA; van Unnik JA; Misdorp W; van Dijk JE
Res Vet Sci; 1992 Sep; 53(2):198-204. PubMed ID: 1332152
[TBL] [Abstract][Full Text] [Related]
37. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
[TBL] [Abstract][Full Text] [Related]
38. Multiple cutaneous fibrous histiocytomas in association with systemic lupus erythematosus.
Yamamoto T; Sumi K; Yokozeki H; Nishioka K
J Dermatol; 2005 Aug; 32(8):645-9. PubMed ID: 16334865
[TBL] [Abstract][Full Text] [Related]
39. Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas.
Soini Y; Salo T; Oikarinen A; Autio-Harmainen H
Lab Invest; 1993 Sep; 69(3):305-11. PubMed ID: 8397322
[TBL] [Abstract][Full Text] [Related]
40. Chemically induced transplantable malignant fibrous histiocytoma of the rat. Analyses with immunohistochemistry, immunoelectron microscopy and [3H]thymidine autoradiography.
Kato T; Takeya M; Takagi K; Takahashi K
Lab Invest; 1990 May; 62(5):635-45. PubMed ID: 2160564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
